Kyra-Verena Sendt

894 total citations
18 papers, 614 citations indexed

About

Kyra-Verena Sendt is a scholar working on Psychiatry and Mental health, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kyra-Verena Sendt has authored 18 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kyra-Verena Sendt's work include Schizophrenia research and treatment (10 papers), Neuroscience and Neuropharmacology Research (4 papers) and Functional Brain Connectivity Studies (4 papers). Kyra-Verena Sendt is often cited by papers focused on Schizophrenia research and treatment (10 papers), Neuroscience and Neuropharmacology Research (4 papers) and Functional Brain Connectivity Studies (4 papers). Kyra-Verena Sendt collaborates with scholars based in United Kingdom, Ireland and United States. Kyra-Verena Sendt's co-authors include Derek K. Tracy, Sagnik Bhattacharyya, Rachel Tribe, Alice Egerton, Philip McGuire, Grant McQueen, Giovanni Giaroli, James H. MacCabe, Amy Gillespie and Gareth J. Barker and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychological Medicine and Neuropsychopharmacology.

In The Last Decade

Kyra-Verena Sendt

17 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyra-Verena Sendt United Kingdom 11 321 165 123 116 91 18 614
Amy Gillespie United Kingdom 11 225 0.7× 143 0.9× 98 0.8× 71 0.6× 86 0.9× 21 517
Anna Mané Spain 18 583 1.8× 149 0.9× 222 1.8× 89 0.8× 82 0.9× 70 902
Tiffany Farchione United States 12 325 1.0× 256 1.6× 224 1.8× 120 1.0× 136 1.5× 23 875
Marie Raffin France 16 454 1.4× 121 0.7× 178 1.4× 116 1.0× 66 0.7× 30 766
Michela Sala Italy 10 227 0.7× 276 1.7× 113 0.9× 56 0.5× 36 0.4× 16 606
Thomas Bronisch Germany 14 196 0.6× 410 2.5× 95 0.8× 72 0.6× 126 1.4× 36 802
Fernando Sarramea Spain 21 482 1.5× 110 0.7× 382 3.1× 139 1.2× 119 1.3× 48 968
Ruth Ohlsen United Kingdom 14 439 1.4× 98 0.6× 177 1.4× 60 0.5× 32 0.4× 38 708
J.P. Lindenmayer United States 11 820 2.6× 319 1.9× 176 1.4× 59 0.5× 120 1.3× 17 1.1k
Nikos C. Stefanis Greece 13 258 0.8× 135 0.8× 64 0.5× 54 0.5× 69 0.8× 48 609

Countries citing papers authored by Kyra-Verena Sendt

Since Specialization
Citations

This map shows the geographic impact of Kyra-Verena Sendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyra-Verena Sendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyra-Verena Sendt more than expected).

Fields of papers citing papers by Kyra-Verena Sendt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyra-Verena Sendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyra-Verena Sendt. The network helps show where Kyra-Verena Sendt may publish in the future.

Co-authorship network of co-authors of Kyra-Verena Sendt

This figure shows the co-authorship network connecting the top 25 collaborators of Kyra-Verena Sendt. A scholar is included among the top collaborators of Kyra-Verena Sendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyra-Verena Sendt. Kyra-Verena Sendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gillespie, Amy, Emma Walker, Eilís Hannon, et al.. (2024). Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts. Translational Psychiatry. 14(1). 390–390. 3 indexed citations
2.
Zelaya, Fernando, Kyra-Verena Sendt, Grant McQueen, et al.. (2024). Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow. SHILAP Revista de lepidopterología. 10(1). 122–122.
3.
Chung, Raymond T., John Lally, Grant McQueen, et al.. (2023). Changes in immunoglobulin levels during clozapine treatment in schizophrenia. Brain Behavior and Immunity. 115. 223–228. 10 indexed citations
4.
McQueen, Grant, Kyra-Verena Sendt, Amy Gillespie, et al.. (2022). Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia. SHILAP Revista de lepidopterología. 8(1). 13–13. 9 indexed citations
5.
Egerton, Alice, J.F.W. Deakin, Richard Drake, et al.. (2022). Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration. Neuropsychopharmacology. 48(3). 567–575. 14 indexed citations
6.
McQueen, Grant, Kyra-Verena Sendt, Amy Gillespie, et al.. (2020). Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia. Schizophrenia Bulletin. 47(3). 662–671. 45 indexed citations
7.
Merritt, Kate, Rocío Pérez‐Iglesias, Kyra-Verena Sendt, et al.. (2019). Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate. Schizophrenia. 5(1). 12–12. 26 indexed citations
8.
Hickling, Lauren M., Rocío Pérez‐Iglesias, Ann McNeill, et al.. (2018). A pre-post pilot study of electronic cigarettes to reduce smoking in people with severe mental illness. Psychological Medicine. 49(6). 1033–1040. 29 indexed citations
9.
Gillespie, Amy, et al.. (2018). Biological Predictors of Clozapine Response: A Systematic Review. Frontiers in Psychiatry. 9. 327–327. 45 indexed citations
10.
Egerton, Alice, Brian V. Broberg, Neeltje E.M. van Haren, et al.. (2018). Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE). Molecular Psychiatry. 23(11). 2145–2155. 86 indexed citations
11.
Krivoy, Amir, et al.. (2017). Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment. Schizophrenia Research. 192. 226–231. 26 indexed citations
12.
Tribe, Rachel, Kyra-Verena Sendt, & Derek K. Tracy. (2017). A systematic review of psychosocial interventions for adult refugees and asylum seekers. Journal of Mental Health. 28(6). 662–676. 61 indexed citations
13.
Marques, Tiago Reis, et al.. (2016). Poster #M178: White matter integrity in treatment-refractory schizophrenia:a diffusion tensor imaging study. Research Portal (King's College London). 4 indexed citations
14.
Mercer, Louise, et al.. (2015). Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia. Journal of Psychopharmacology. 29(2). 197–211. 35 indexed citations
15.
Sendt, Kyra-Verena, Derek K. Tracy, & Sagnik Bhattacharyya. (2014). A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders. Psychiatry Research. 225(1-2). 14–30. 184 indexed citations
16.
Tracy, Derek K., Kyra-Verena Sendt, & Sukhwinder S. Shergill. (2013). Antipsychotic Polypharmacy: Still Dirty, But Hardly a Secret. A Systematic Review and Clinical Guide. Research Portal (King's College London). 2(2). 143–171. 9 indexed citations
17.
Bhattacharyya, Sagnik & Kyra-Verena Sendt. (2012). Neuroimaging Evidence for Cannabinoid Modulation of Cognition and Affect in Man. Frontiers in Behavioral Neuroscience. 6. 22–22. 6 indexed citations
18.
Sendt, Kyra-Verena, Giovanni Giaroli, & Derek K. Tracy. (2012). Beyond Dopamine: Glutamate as a Target for Future Antipsychotics. PubMed. 2012. 1–9. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Gillespie Breakdown of academic impact, for papers by Anna Mané Breakdown of academic impact, for papers by Tiffany Farchione Breakdown of academic impact, for papers by Marie Raffin Breakdown of academic impact, for papers by Michela Sala Breakdown of academic impact, for papers by Thomas Bronisch Breakdown of academic impact, for papers by Fernando Sarramea Breakdown of academic impact, for papers by Ruth Ohlsen Breakdown of academic impact, for papers by J.P. Lindenmayer Breakdown of academic impact, for papers by Nikos C. Stefanis
Rankless by CCL
2026